O'Shaughnessy, J., Woeckel, A., Pistilli, B., Hegg, R., Vahdat, L. T., Vuina, D., . . . Krop, I. (2022 Supplement 16). Clinical outcomes with alpelisib (ALP) plus fulvestrant (FUL) after prior treatment (tx) with FUL in patients (pts) with advanced breast cancer (ABC): A real-world (RW) analysis. Journal of Clinical Oncology, 40, 1055-1056.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
O'Shaughnessy, Joyce, et al. "Clinical Outcomes with Alpelisib (ALP) Plus Fulvestrant (FUL) After Prior Treatment (tx) with FUL in Patients (pts) with Advanced Breast Cancer (ABC): A Real-world (RW) Analysis."
Journal of Clinical Oncology 40 (2022 Supplement 16): 1055-1056.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
O'Shaughnessy, Joyce, et al. "Clinical Outcomes with Alpelisib (ALP) Plus Fulvestrant (FUL) After Prior Treatment (tx) with FUL in Patients (pts) with Advanced Breast Cancer (ABC): A Real-world (RW) Analysis."
Journal of Clinical Oncology, vol. 40, 2022 Supplement 16, pp. 1055-1056.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.